Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells

Molecular and Cellular Biochemistry

Volumn 358, Issue 1-2, 2011, Pages 297-307

  Ogino, Tetsuya ^a   Kobuchi, Hirotsugu ^a   Munetomo, Kazuaki ^a   Fujita, Hirofumi ^a   Yamamoto, Masanao ^a   Utsumi, Toshihiko ^b   Inoue, Keiji ^c   Shuin, Taro ^c   Sasaki, Junzo ^a   Inoue, Masayasu ^d   Utsumi, Kozo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c KOCHI MEDICAL SCHOOL   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Aminolevulinic acid; Albumin; ATP binding cassette transporter G2; Ferrochelatase; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; AMINOLEVULINIC ACID; BOVINE SERUM ALBUMIN; ENZYME INHIBITOR; FERROCHELATASE; HEME; INDOLE DERIVATIVE; NITROSO DERIVATIVE; PROTOPORPHYRIN; TRYPTOQUIVALINE; TUMOR PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; SERUM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

AMINOLEVULINIC ACID; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CATTLE; CELL LINE, TUMOR; ENZYME INHIBITORS; EXTRACELLULAR SPACE; FERROCHELATASE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEME; HUMANS; INDOLES; NEOPLASM PROTEINS; NITROSO COMPOUNDS; PROTOPORPHYRINS; SERUM; SERUM ALBUMIN, BOVINE;

EID: 84857183545     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0980-5     Document Type: Article

References (41)

1. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79:2282-2308
2. Datta SN, Loh CS, MacRobert AJ, Whatley SD, Matthews PN (1998) Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br J Cancer 78:1113-1118
3. Hinnen P, de Rooij FW, van Velthuysen ML, Edixhoven A, van Hillegersberg R, Tilanus HW, Wilson JH, Siersema PD (1998) Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer 78:679-682
4. Krishnamurthy P, Xie T, Schuetz JD (2007) The role of transporters in cellular heme and porphyrin homeostasis. Pharmacol Ther 114:345-358. doi:10.1016/j.pharmthera.2007.02.001
5. Zutz A, Gompf S, Schägger H, Tampé R (2009) Mitochondrial ABC proteins in health and disease. Biochim Biophys Acta 1787:681-690. doi:10.1016/j.bbabio.2009.02.009
6. Ishikawa T, Nakagawa H, Hagiya Y, Nonoguchi N, Miyatake S, Kuroiwa T (2010) Key role of human ABC transporter ABCG2 in photodynamic therapy and photodynamic diagnosis. Adv Pharmacol Sci 2010:587306. doi:10.1155/2010/587306
7. Schoenfeld N, Mamet R, Leibovici L, Epstein O, Teitz Y, Atsmon A (1988) Growth rate determines activity of porphobilinogen deaminase both in nonmalignant and malignant cell lines. Biochem Med Metab Biol 40:213-217
8. Krieg RC, Fickweiler S, Wolfbeis OS, Knuechel R (2000) Celltype specific protoporphyrin IX metabolism in human bladder cancer in vitro. Photochem Photobiol 72:226-233
9. Jonker JW, Musters S, Vlaming ML, Plösch T, Gooijert KE, Hillebrand MJ, Rosing H, Beijnen JH, Verkade HJ, Schinkel AH (2007) Breast cancer resistance protein (Bcrp1/Abcg2) is expressed in the harderian gland and mediates transport of conjugated protoporphyrin IX. Am J Physiol Cell Physiol 292: C2204-C2212. doi:10.1152/ajpcell.00359.2006
10. Zhou S, Zong Y, Ney PA, Nair G, Stewart CF, Sorrentino BP (2005) Increased expression of the Abcg2 transporter during erythroid maturation plays a role in decreasing cellular protoporphyrin IX levels. Blood 105:2571-2576. doi:10.1182/blood-2004-04-1566
11. Asashima T, Hori S, Ohtsuki S, Tachikawa M, Watanabe M, Mukai C, Kitagaki S, Miyakoshi N, Terasaki T (2006) ATPbinding cassette transporter G2 mediates the efflux of phototoxins on the luminal membrane of retinal capillary endothelial cells. Pharm Res 23:1235-1242. doi:10.1007/s11095-006-0067-2
12. Robey RW, Steadman K, Polgar O, Bates SE (2005) ABCG2- mediated transport of photosensitizers: potential impact on photodynamic therapy. Cancer Biol Ther 4:187-194
13. Chu ES, Yow CM, Shi M, Ho RJ (2008) Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells. Toxicol Lett 181:7-12. doi: 10.1016/j.toxlet.2008.06.860
14. Liu W, Baer MR, Bowman MJ, Pera P, Zheng X, Morgan J, Pandey RA, Oseroff AR (2007) The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Clin Cancer Res 13:2463-2470. doi: 10.1158/1078-0432.CCR-06-1599
15. Diestra JE, Scheffer GL, Catala I, Maliepaard M, Schellens JH, Scheper RJ, Germa-Lluch JR, Izquierdo MA (2002) Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol 198:213-219. doi:10.1002/path.1203
16. Morgan J, Jackson JD, Zheng X, Pandey SK, Pandey RK (2010) Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy. Mol Pharm 7:1789-1804. doi:10.1021/mp100154j
17. Sharma S, Jajoo A, Dube A (2007) 5-Aminolevulinic acidinduced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines. J Photochem Photobiol B 88:156-162. doi:10.1016/j. jphotobiol.2007.07.005
18. Rigby CC, Franks LM (1970) A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br J Cancer 24: 746-754
19. Inoue K, Karashima T, Kamada M, Shuin T, Kurabayashi A, Furihata M, Fujita H, Utsumi K, Sasaki J (2009) Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Pathobiology 76:303-314. doi: 10.1159/000245896
20. Hirai K, Sasahira T, Ohmori H, Fujii K, Kuniyasu H (2007) Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 120:500-505. doi:10.1002/ijc.22287
21. Wyld L, Burn JL, Reed MW, Brown NJ (1997) Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br J Cancer 76:705-712
22. Arita K, Yamamoto Y, Takehara Y, Utsumi T, Kanno T, Miyaguchi C, Akiyama J, Yoshioka T, Utsumi K (2003) Mechanisms of enhanced apoptosis in HL-60 cells by UV-irradiated n-3 and n- 6 polyunsaturated fatty acids. Free Radic Biol Med 35:189-199
23. Liu YL, Ang SO, Weigent DA, Prchal JT, Bloomer JR (2004) Regulation of ferrochelatase gene expression by hypoxia. Life Sci 75:2035-2043. doi:10.1016/j.lfs.2004.03.027
24. Furukawa T, Wakabayashi K, Tamura A, Nakagawa H, Morishima Y, Osawa Y, Ishikawa T (2009) Major SNP (Q141 K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations. Pharm Res 26:469-479. doi: 10.1007/s11095-008-9752-7
25. Gewin L, Galloway DA (2001) E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J Virol 75:7198-7201. doi:10.1128/JVI.75.15.7198-7201.2001
26. Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q (2006) Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. J Photochem Photobiol B 84:213-220. doi:10.1016/j.jphotobiol.2006.03.006
27. Evseenko DA, Murthi P, Paxton JW, Reid G, Emerald BS, Mohankumar KM, Lobie PE, Brennecke SP, Kalionis B, Keelan JA (2007) The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J 21:3592-3605. doi:10.1096/fj.07-8688com
28. Okimura Y, Fujita H, Ogino T, Inoue K, Shuin T, Yano H, Yasuda T, Inoue M, Utsumi K, Sasaki J (2007) Regulation of 5-aminolevulinic acid-dependent protoporphyrin IX accumulations in human histiocytic lymphoma U937 cells. Physiol Chem Phys Med NMR 39:69-82
29. Amo T, Kawanishi N, Uchida M, Fujita H, Oyanagi E, Utsumi T, Ogino T, Inoue K, Shuin T, Utsumi K, Sasaki J (2009) Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937. Cell Biochem Funct 27:503-515. doi:10.1002/cbf.1603
30. Gibson SL, Havens JJ, Metz L, Hilf R (2001) Is delta-aminolevulinic acid dehydratase rate limiting in heme biosynthesis following exposure of cells to delta-aminolevulinic acid? Photochem Photobiol 73:312-317
31. Fukuda H, Batlle AM, Riley PA (1993) Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA. Int J Bioch 25:1407-1410
32. Ding Y, Lin B, Huie CW (2001) Binding studies of porphyrins to human serum albumin using affinity capillary electrophoresis. Electrophoresis 22:2210-2216. doi:10.1002/1522-2683(20017) 22:11\2210:AID-ELPS2210[3.0.CO;2-W
33. Taketani S, Kakimoto K, Ueta H, Masaki R, Furukawa T (2003) Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood 101: 3274-3280. doi:10.1182/blood-2002-04-1212
34. Susanto J, Lin YH, Chen YN, Shen CR, Yan YT, Tsai ST, Chen CH, Shen CN (2008) Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells. PLoS One 3:e4023. doi:10.1371/journal.pone.0004023
35. Yamamoto K, Suzu S, Yoshidomi Y, Hiyoshi M, Harada H, Okada S (2007) Erythroblasts highly express the ABC transporter Bcrp1/ABCG2 but do not show the side population (SP) phenotype. Immunol Lett 114:52-58. doi:10.1016/j.imlet. 2007.08.008
36. Kriska T, Korytowski W, Girotti AW (2002) Hyperresistance to photosensitized lipid peroxidation and apoptotic killing in 5-aminolevulinate- treated tumor cells overexpressing mitochondrial GPX4. Free Radic Biol Med 33:1389-1402
37. Kriska T, Korytowski W, Girotti AW (2005) Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells. Arch Biochem Biophys 433:435-446. doi:10.1016/j.abb.2004.09.025
38. Schoenfeld N, Mamet R, Nordenberg Y, Shafran M, Babushkin T, Malik Z (1994) Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Int J Cancer 56: 106-112
39. Desuzinges-Mandon E, Arnaud O, Martinez L, Huché F, Di Pietro A, Falson P (2010) ABCG2 transports and transfers heme to albumin through its large extracellular loop. J Biol Chem 285:33123-33133. doi:10.1074/jbc.M110.139170
40. Solazzo M, Fantappie O, D'Amico M, Sassoli C, Tani A, Cipriani G, Bogani C, Formigli L, Mazzanti R (2009) Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res 69:7235-7242. doi:10.1158/0008-5472.CAN- 08-4315
41. Frank J, Lornejad-Schäfer MR, Schöffl H, Flaccus A, Lambert C, Biesalski HK (2007) Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int J Oncol 31:1539-1545